The biosimilar market is gaining strong momentum as healthcare systems globally strive to contain spending while maintaining high-quality patient care. Biosimilars provide clinically equivalent therapeutic outcomes at significantly lower costs compared to reference biologics https://www.imarcgroup.com/biosimilar-market